Logo for "SAMUEL WAXMAN CANCER RESEARCH FOUNDATION FOUNDATION"

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION FOUNDATION

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION FOUNDATION

New York, NY, US
501(c)3
EIN
13-3020943
Logo for "SAMUEL WAXMAN CANCER RESEARCH FOUNDATION FOUNDATION"

SAMUEL WAXMAN CANCER RESEARCH FOUNDATION FOUNDATION

New York, NY, US
501(c)3
EIN
13-3020943

Balance Sheet

Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)

$5,376,278

Investments
41%
Receivables (Non-Related)
39%
Prepaid Expenses
7%
Other Assets
6%
Cash & Equivalents
6%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)

$558,705

Other Liabilities
56%
Deferred Revenue
31%
Payables & Accruals
13%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$290,431
$334,794
+15%
Receivables (Non-Related)
$2,889,682
$2,091,391
-28%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$340,714
$369,717
+9%
Investments
$2,550,233
$2,224,964
-13%
Property, Plant, & Equipment (net)
$26,239
$19,111
-27%
Other Assets
$78,264
$336,301
+330%
Total Assets
$6,175,563
$5,376,278
-13%
Liabilities
2023
2024
Change
Payables & Accruals
$88,979
$72,777
-18%
Grants Payable
$0
$0
-
Deferred Revenue
$161,823
$172,902
+7%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$59,583
$313,026
+425%
Total Liabilities
$310,385
$558,705
+80%
Net assets
2023
2024
Change
Restricted Net Assets
$2,859,297
$1,941,297
-32%
Unrestricted Net Assets
$3,005,881
$2,876,276
-4%
Net assets
2023
2024
Change
Net assets
+$5,865,178
+$4,817,573
-18%
Balance Sheet
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)